Management and Pharmacological Treatment of Peripheral Arterial Disease

被引：3

作者：

Leatham, Samantha J. ^{[1
]}

Winckel, Karl R. ^{[1
,2
]}

De Guzman, Keshia R. ^{[1
,2
]}

机构：

[1] Princess Alexandra Hosp, Dept Pharm, 199 Ipswich Rd, Brisbane, Qld 4102, Australia

[2] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia

来源：

JOURNAL OF PHARMACY PRACTICE | 2024年 / 37卷 / 06期

关键词：

peripheral arterial disease; revascularisation; pharmacological management; antithrombotic therapy; CONVERTING-ENZYME-INHIBITOR; AMPUTATION-FREE SURVIVAL; DRUG-COATED BALLOON; INTERMITTENT CLAUDICATION; HIGH-RISK; CARDIOVASCULAR EVENTS; ELUTING STENT; TRIAL; ANGIOPLASTY; ASSOCIATION;

D O I：

10.1177/08971900241250084

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Background: Peripheral arterial disease (PAD) is a complex, heterogeneous condition that has become a leading health concern globally. Peripheral arterial disease often co-exists with other vascular disease states, including cerebrovascular and cardiovascular disease. Optimal therapy for managing symptoms and progression of disease employs non-pharmacological, pharmacological, and contemporary revascularisation techniques to improve clinical outcomes and quality of life. However, large well-designed randomised control trials (RCT) and corresponding evidence-based guidelines for management of PAD are lacking, with current practice standards often extrapolated from evidence in coronary artery disease.Purpose: This review article aims to discuss currently accepted best pharmacological practice for PAD.Method: Relevant articles were searched between May 2023 and January 2024 through PubMed, Cochrane Library, Google Scholar and international guidelines, focusing on pharmacological management for PAD.Results: This narrative review discusses holistic pharmacological treatments for PAD.

引用

页码：1337 / 1345

页数：9

共 85 条

[1] 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS [J].

Aboyans, Victor ;

Ricco, Jean-Baptiste ;

Bartelink, Marie-Louise E. L. ;

Bjoerck, Martin ;

Brodmann, Marianne ;

Cohnert, Tina ;

Collet, Jean-Philippe ;

Czerny, Martin ;

De Carlo, Marco ;

Debus, Sebastian ;

Espinola-Klein, Christine ;

Kahan, Thomas ;

Kownator, Serge ;

Mazzolai, Lucia ;

Naylor, A. Ross ;

Roffi, Marco ;

Roether, Joachim ;

Sprynger, Muriel ;

Tendera, Michal ;

Tepe, Gunnar ;

Venermo, Maarit ;

Vlachopoulos, Charalambos ;

Desormais, Ileana .

KARDIOLOGIA POLSKA, 2017, 75 (11) :1065-1160

[2]

Aday AW., 2020, CIRC-CARDIOVASC INTE, V13, P1

[3] RETRACTED: Effect of Ramipril on Walking Times and Quality of Life Among Patients With Peripheral Artery Disease and Intermittent Claudication A Randomized Controlled Trial (Retracted Article) [J].

Ahimastos, Anna A. ;

Walker, Philip J. ;

Askew, Christopher ;

Leicht, Anthony ;

Pappas, Elise ;

Blombery, Peter ;

Reid, Christopher M. ;

Golledge, Jonathan ;

Kingwell, Bronwyn A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (05) :453-460

[4] Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia [J].

Armstrong, Ehrin J. ;

Chen, Debbie C. ;

Singh, Gagan D. ;

Amsterdam, Ezra A. ;

Laird, John R. .

VASCULAR MEDICINE, 2015, 20 (03) :237-244

[5]

Banerjee S., 2021, ANTIPLATELET STRATEG

[6] Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement [J].

Belch, Jill J. F. ;

Brodmann, Marianne ;

Baumgartner, Iris ;

Binder, Christoph J. ;

Casula, Manuela ;

Heiss, Christian ;

Kahan, Thomas ;

Parini, Paolo ;

Poredos, Pavel ;

Catapano, Alberico L. ;

Tokgozoglu, Lale .

ATHEROSCLEROSIS, 2021, 338 :55-63

[7] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].

Bhatt, DL ;

Fox, KAA ;

Hacke, W ;

Berger, PB ;

Black, HR ;

Boden, WE ;

Cacoub, P ;

Cohen, EA ;

Creager, MA ;

Easton, JD ;

Flather, MD ;

Haffner, SM ;

Hamm, CW ;

Hankey, GJ ;

Johnston, SC ;

Mak, KH ;

Mas, JL ;

Montalescot, G ;

Pearson, TA ;

Steg, PG ;

Steinhubl, SR ;

Weber, MA ;

Brennan, DM ;

Fabry-Ribaudo, L ;

Booth, J ;

Topol, EJ ;

Frye, RL ;

Amarenco, P ;

Brass, LM ;

Buyse, M ;

Cohen, LS ;

DeMets, DL ;

Fuster, V ;

Hart, RG ;

Marler, JR ;

McCarthy, C ;

Schoemig, A ;

Lincoff, AM ;

Brener, SJ ;

Sila, CA ;

Albuquerque, A ;

Aroutiounov, G ;

Artemiev, D ;

Atkeson, BG ;

Bartel, T ;

Basart, DCG ;

Lima, AB ;

Belli, G ;

Bordalo e Sa, AL ;

Bosch, X .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717

[8] Rivaroxaban in Peripheral Artery Disease after Revascularization [J].

Bonaca, Marc P. ;

Bauersachs, Rupert M. ;

Anand, Sonia S. ;

Debus, E. Sebastian ;

Nehler, Mark R. ;

Patel, Manesh R. ;

Fanelli, Fabrizio ;

Capell, Warren H. ;

Diao, Lihong ;

Jaeger, Nicole ;

Hess, Connie N. ;

Pap, Akos F. ;

Kittelson, John M. ;

Gudz, Ivan ;

Matyas, Lajos ;

Krievins, Dainis K. ;

Diaz, Rafael ;

Brodmann, Marianne ;

Muehlhofer, Eva ;

Haskell, Lloyd P. ;

Berkowitz, Scott D. ;

Hiatt, William R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21) :1994-2004

[9] Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease [J].

Bonaca, Marc P. ;

Bhatt, Deepak L. ;

Storey, Robert F. ;

Steg, Gabriel ;

Cohen, Marc ;

Kuder, Julia ;

Goodrich, Erica ;

Nicolau, Jose C. ;

Parkhomenko, Alexander ;

Lopez-Sendon, Jose ;

Dellborg, Mikael ;

Dalby, Anthony ;

Spinar, Jindrich ;

Aylward, Philip ;

Corbalan, Ramon ;

Abola, Maria Teresa B. ;

Jensen, Eva C. ;

Held, Peter ;

Braunwald, Eugene ;

Sabatine, Marc S. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (23) :2719-2728

[10] Pentoxifylline for intermittent claudication [J].

Broderick, Cathryn ;

Forster, Rachel ;

Abdel-Hadi, Mohammed ;

Salhiyyah, Kareem .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (10)

← 1 2 3 4 5 6 7 8 9 →